Lomtegovimab
Lomtegovimab (BI 767551) is a human anti-SARS-COV-2 spike glycoprotein monoclonal antibody. Lomtegovimab binds and neutralizes SARS-CoV-2. Lomtegovimab shows antiviral efficacy. Lomtegovimab has the potential for the research of COVID-19[1][2].
Product Specifications
CAS Number
2550869-33-3
Product Name Alternative
BI 767551; DZIF-10c
UNSPSC
12352203
Target
SARS-CoV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/lomtegovimab.html
Purity
99.94
Solubility
10 mM in DMSO
Smiles
[Lomtegovimab]
Molecular Weight
(145.58 kDa)
References & Citations
[1]Halwe S, et al. Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection. Viruses. 2021 Jul 29;13 (8) :1498.|[2]Halwe S, et al. Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection. Viruses. 2021 Jul 29;13 (8) :1498.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K0631205 3x 1.0 µg
DPYSL3 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details bs-2470R-BF350-01 20 µL
CD244 Polyclonal Antibody, AbBy Fluor™ 350 Conjugated
Sign In for Pricing
View Details bs-2470R-BF350-02 100 µL
CD244 Polyclonal Antibody, AbBy Fluor™ 350 Conjugated
Sign In for Pricing
View Details